Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Maes

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trialJohan Scharpé, Willy E Peetermans, Johan Vanwalleghem, et al.
The American Journal of Gastroenterology|February 20, 2003
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitisGert Van Assche, Ignace Dalle, Maja Noman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2017
Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction: an observational studySteven Van Laecke, Tessa Kerre, Evi V Nagler, et al.
Transplantation|May 10, 2005
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trialBengt Fellström, Alan G Jardine, Inga Soveri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosisBart Maes, Michael Oellerich, Jan L Ceuppens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2007
Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis populationWim Terryn, Bruce Poppe, Birgitte Wuyts, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Inflammation in renal transplantationSadollah Abedini, Ingar Holme, Winfried März, et al.
Kidney International Reports|May 14, 2023
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V Rizk, Brad H Rovin, Hong Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipientsGert De Schoenmakere, Bruce Poppe, Birgitte Wuyts, et al.
Kidney International Reports|January 16, 2026
Iptacopan in Patients With IgA Nephropathy From East AsiaHong Zhang, Vlado Perkovic, Jonathan Barratt, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trialJohan Scharpé, Willy E Peetermans, Johan Vanwalleghem, et al.
The American Journal of Gastroenterology|February 20, 2003
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitisGert Van Assche, Ignace Dalle, Maja Noman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2017
Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction: an observational studySteven Van Laecke, Tessa Kerre, Evi V Nagler, et al.
Transplantation|May 10, 2005
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trialBengt Fellström, Alan G Jardine, Inga Soveri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosisBart Maes, Michael Oellerich, Jan L Ceuppens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2007
Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis populationWim Terryn, Bruce Poppe, Birgitte Wuyts, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Inflammation in renal transplantationSadollah Abedini, Ingar Holme, Winfried März, et al.
Kidney International Reports|May 14, 2023
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V Rizk, Brad H Rovin, Hong Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipientsGert De Schoenmakere, Bruce Poppe, Birgitte Wuyts, et al.
Kidney International Reports|January 16, 2026
Iptacopan in Patients With IgA Nephropathy From East AsiaHong Zhang, Vlado Perkovic, Jonathan Barratt, et al.
Pageof 8